Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial
Titel:
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial
Auteur:
Manno, Daniela Bangura, Agnes Baiden, Frank Kamara, Abu Bakarr Ayieko, Philip Kallon, Joseph Foster, Julie Conteh, Musa Connor, Nicholas Edward Koroma, Bockarie Njie, Yusupha Borboh, Paul Keshinro, Babajide Lawal, Bolarinde Joseph Kroma, Mattu Tehtor Otieno, Godfrey Tuda Deen, Abdul Tejan Choi, Edward Man-Lik Balami, Ahmed Dahiru Gaddah, Auguste McLean, Chelsea Luhn, Kerstin Adetola, Hammed Hassan Deen, Gibrilla Fadlu Samai, Mohamed Lowe, Brett Robinson, Cynthia Leigh, Bailah Greenwood, Brian Watson-Jones, Deborah